Eikon Therapeutics to join Russell 3000 index
Seeking Alpha ·
Eikon Therapeutics ( EIKN ) will be added to the Russell 3000 Index following the annual reconstitution, effective after the U.S. market closes on June 26. The Russell 3000 tracks about 3,000 U.S. stocks and represents roughly 98% of the investable U.S. equity market, spanning large-, mid-, and small-cap companies. Eikon Therapeutics: Buy TLR Combinatory Potential Only After Lock-Up Expiry Eikon Therapeutics: Initiating Coverage With A Cautious Buy Rating Largest IPOs of the last 90 days register mixed debut Historical earnings data for Eikon Therapeutics, Inc. Financial information for Eikon Therapeutics, Inc.
DYAX Investor Sentiment
Bullish (Long) 42% · Bearish (Short) 58%
476 participants
Related News
- TechnipFMC wins contract up to $1B from Vaar Energi for North Sea project
- Stock Market Today, June 25: Apple Drops After Raising Device Prices to Offset Higher Memory Costs
- Medexus Pharmaceuticals reports Q4 results
- Vallant Financial announces ten-for-one stock split
- 리포메이션, 소매 입지 확장 위해 뉴욕증권거래소 IPO 신청
- Investors Are Getting Another Great Opportunity to Buy This Incredible Artificial Intelligence (AI) Stock Right Now